• Subscribe

No Margin for Error

The unprecedented scheduling challenges of cell and gene therapy manufacturing

Cell and gene therapy represents a totally different paradigm for biomanufacturers, complete with its own challenges. Very careful orchestration of the supply chain network is necessary to manage the unique elements of patients, health care providers and blood into the supply chain and the impact they have on real-time rescheduling within the manufacturing environment. Watch the short video below to see some key considerations.

About the Author

Smart Scheduling Team
Smart Scheduling Team
The SmartFactory Rx Team develops integrated automation solutions for process manufacturing to harness the power of data, reduce development time and improve productivity to optimize high value manufacturing. It increases throughput, decreases risk, and accelerates time to market for new products. For more details, connect with us on LinkedIn.